KELLY VANWYCK: Open Payments
NPI 1104334655 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 24 payments from 10 companies in 2025. Trend: 2023 $482 · 2024 $382 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $140 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| PFIZER INC. | 3 | $52 |
| Exact Sciences Corporation | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Astellas Pharma US Inc | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: REXULTI, Cologuard Collection Kit, CAPLYTA, PREVNAR 20, Wegovy, Ozempic, Veozah, Auvelity.
Industry payments across NJ — which companies pay providers there.
